ArticleAging2021

Bortezomib enhances the anti-cancer effect of the novel Bruton's tyrosine kinase inhibitor (BGB-3111) in mantle cell lymphoma expressing BTK.

Xianhuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.